Milsom P, Smith R, Baker P, Walls H
Global Health. 2021; 17(1):134.
PMID: 34819083
PMC: 8611909.
DOI: 10.1186/s12992-021-00784-3.
Koivusalo M, Heinonen N, Tynkkynen L
Global Health. 2021; 17(1):98.
PMID: 34461935
PMC: 8404176.
DOI: 10.1186/s12992-021-00739-8.
van Schalkwyk M, Barlow P, Siles-Brugge G, Jarman H, Hervey T, Mckee M
Global Health. 2021; 17(1):61.
PMID: 34107982
PMC: 8188541.
DOI: 10.1186/s12992-021-00697-1.
Milsom P, Smith R, Baker P, Walls H
Health Policy Plan. 2020; 36(4):493-508.
PMID: 33276385
PMC: 8128013.
DOI: 10.1093/heapol/czaa148.
Hawkins B, McCambridge J
Scott Aff. 2020; 29(1):3-23.
PMID: 32733118
PMC: 7357823.
DOI: 10.3366/scot.2020.0304.
Defending Comprehensive Tobacco Control Policy Implementation in Nepal From Tobacco Industry Interference (2011-2018).
Bhatta D, Crosbie E, Bialous S, Glantz S
Nicotine Tob Res. 2020; 22(12):2203-2212.
PMID: 32309853
PMC: 7733063.
DOI: 10.1093/ntr/ntaa067.
Standardised packaging, minimum excise tax, and RYO focussed tax rise implications for UK tobacco pricing.
Hiscock R, Augustin N, Branston J, Gilmore A
PLoS One. 2020; 15(2):e0228069.
PMID: 32053603
PMC: 7017998.
DOI: 10.1371/journal.pone.0228069.
Corporations' use and misuse of evidence to influence health policy: a case study of sugar-sweetened beverage taxation.
Fooks G, Williams S, Box G, Sacks G
Global Health. 2019; 15(1):56.
PMID: 31551086
PMC: 6760066.
DOI: 10.1186/s12992-019-0495-5.
European Union implementation of Article 5.3 of the Framework Convention on Tobacco Control.
Hawkins B, Holden C
Global Health. 2018; 14(1):79.
PMID: 30071862
PMC: 6090908.
DOI: 10.1186/s12992-018-0386-1.
Impact of the WHO FCTC over the first decade: a global evidence review prepared for the Impact Assessment Expert Group.
Chung-Hall J, Craig L, Gravely S, Sansone N, Fong G
Tob Control. 2018; 28(Suppl 2):s119-s128.
PMID: 29880598
PMC: 6589489.
DOI: 10.1136/tobaccocontrol-2018-054389.
Influencing trade policy in a multi-level system - Understanding corporate political activity in the context of global value chains and regime complexity.
Curran L, Eckhardt J
Bus Polit. 2018; 20(1):132-164.
PMID: 29527122
PMC: 5842924.
DOI: 10.1017/bap.2017.26.
A multi-level, multi-jurisdictional strategy: Transnational tobacco companies' attempts to obstruct tobacco packaging restrictions.
Hawkins B, Holden C, Mackinder S
Glob Public Health. 2018; 14(4):570-583.
PMID: 29521160
PMC: 6129412.
DOI: 10.1080/17441692.2018.1446997.
Disentangling regional trade agreements, trade flows and tobacco affordability in sub-Saharan Africa.
Appau A, Drope J, Labonte R, Stoklosa M, Lencucha R
Global Health. 2017; 13(1):81.
PMID: 29137678
PMC: 5686832.
DOI: 10.1186/s12992-017-0305-x.
The Trans-Pacific Partnership: Should We "Fear the Fear"? Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?".
Walls H, Hanefeld J, Smith R
Int J Health Policy Manag. 2017; 6(6):353-355.
PMID: 28812829
PMC: 5458798.
DOI: 10.15171/ijhpm.2016.140.
Smoke screen? The globalization of production, transnational lobbying and the international political economy of plain tobacco packaging.
Curran L, Eckhardt J
Rev Int Polit Econ. 2017; 24(1):87-118.
PMID: 28630533
PMC: 5473340.
DOI: 10.1080/09692290.2016.1269658.
Tobacco industry globalization and global health governance: towards an interdisciplinary research agenda.
Lee K, Eckhardt J, Holden C
Palgrave Commun. 2017; 2.
PMID: 28458910
PMC: 5409523.
DOI: 10.1057/palcomms.2016.37.
Tobacco packaging design for reducing tobacco use.
McNeill A, Gravely S, Hitchman S, Bauld L, Hammond D, Hartmann-Boyce J
Cochrane Database Syst Rev. 2017; 4:CD011244.
PMID: 28447363
PMC: 6478110.
DOI: 10.1002/14651858.CD011244.pub2.
Controlling corporate influence in health policy making? An assessment of the implementation of article 5.3 of the World Health Organization framework convention on tobacco control.
Fooks G, Smith J, Lee K, Holden C
Global Health. 2017; 13(1):12.
PMID: 28274267
PMC: 5343400.
DOI: 10.1186/s12992-017-0234-8.
Assessing the health impact of transnational corporations: a case study on McDonald's Australia.
Anaf J, Baum F, Fisher M, Harris E, Friel S
Global Health. 2017; 13(1):7.
PMID: 28166801
PMC: 5295215.
DOI: 10.1186/s12992-016-0230-4.
A Corporate Veto on Health Policy? Global Constitutionalism and Investor-State Dispute Settlement.
Hawkins B, Holden C
J Health Polit Policy Law. 2016; 41(5):969-95.
PMID: 27256810
PMC: 5040601.
DOI: 10.1215/03616878-3632203.